9 results
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
, Texas, and served as Laboratory Director. During his tenure at Oncopath, he commercialized eight LDTs, including bringing to market a proprietary cancer
POS AM
BIAF
BioAffinity Technologies Inc
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
the Oncopath Laboratory – START Cancer Center in San Antonio, Texas, and served as Laboratory Director. During his tenure at Oncopath, he commercialized eight
8-K
5puh7
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
DEF 14A
fzc8vpbf793qoxh6djas
1 May 23
Definitive proxy
2:55pm
PRE 14A
8ghgnl
19 Apr 23
Preliminary proxy
9:56pm
- Prev
- 1
- Next